With nearly $3.4B raised, Frazier Healthcare Partners is a leading provider of growth and venture capital to healthcare companies, focusing on Life Sciences and Growth Buyout investments.

Life Sciences

Acquired by AstraZeneca in 2016
IPO in 2017 (NASDAQ: ANAB)
Acquired by Valeant Pharmaceuticals in 2014
Acquired by Allergan in 2016

Growth Buyout

Acquired by McKesson Corporation
Acquired by The Partners Group



Pharma Packager PCI Sells for More Than $1 Billion

Matrix Medical Network

Providence Service Corporation and Frazier Healthcare Partners Complete Formation of Strategic Partnership in Matrix Medical Network

Frazier Healthcare Partners

Frazier Healthcare Partners Closes Oversubscribed $419 Million Life Sciences Fund


Roche and Ignyta Reach Definitive Merger Agreement